The US has imposed up to 100% tariffs on patented drugs and certain metals, aiming to boost domestic manufacturing. While India’s generic drug exports are largely exempt, firms producing branded medicines or inputs for patented drugs may face pressure. Developed nations are expected to bear the brunt of these new measures.
